Importance Immune checkpoint inhibitors (ICIs) are part of standard of care for patients with
many advanced solid tumors. Patients with poor performance status or organ dysfunction …

Background Patients with metastatic bladder cancer have very poor prognosis and
predictive biomarkers are urgently needed for early clinical detection and intervention. In this …

As a member of PHB (prohibitin1) family, PHB plays important roles in many cancers, but its
property in bladder carcinoma aggressiveness is unknown. This research was to explore the …

Background Solid organ transplant recipients are at increased risk for developing
malignancies. Polyomaviruses (PV) have been historically associated with experimental …

Purpose To test for survival differences in metastatic urothelial carcinoma of the urinary
bladder (mUCUB) patients, according to years of diagnosis, age, sex, and race/ethnicity over …

Background Bladder cancer (BC) survival has shown no significant improvement. This study
investigated the trends in the common causes of death among patients with BC to improve …

Purpose We sought to identify the method that could obtain the best survival rate for AJCC
stage IV bladder cancer (BCa) patients. Methods Patients with AJCC stage IV BCa …

Background: Spindle cell carcinoma (SpCC) is a rare tumor type with poor prognosis, and
standard treatment modalities are not available yet. However, large-scale studies on this …

Cancer is the most deadly disease that causes death among the world. It is caused by
genome and epigenome abnormalities. Herbal plants are used for treatment of cancer …

Urothelial carcinoma is a frequent worldwide malignancy. Poor survival rates in muscle-
invasive and metastatic urothelial carcinoma impose major challenges for management. We …